Catalyst Event
Novartis AG (NVS) · Earnings Release
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
7/21/2026, 12:00:00 AM
Second quarter 2026 financial results for 2026-07-21; low importance estimated as the date is a routine reporting event with an expected impact of approximately 1% scheduled.
Korean Translation
2026년 7월 21일, 2026년 2분기 재무 실적 발표 예정됨. 정기적인 실적 발표 일정으로 약 1% 수준의 낮은 영향이 예상됨.
Related Recent Events
Life Time Group Holdings Inc (LTH) · Earnings Release
Q2 2026 earnings release on 2026-08-04 with analyst EPS forecast of $0.43; low importance estimated due to no current market impact, expected.
8/4/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott is expected to announce its Q2 2026 earnings results on July 16, 2026. This key quarterly financial update is estimated to have a moderate price impact of at least 5%, scheduled.
7/16/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Other
FDA action date (PDUFA) for supplemental applications for WELIREG in combination with KEYTRUDA for the adjuvant treatment of certain patients with renal cell carcinoma (RCC) is scheduled for June 19, 2026, scheduled.
6/19/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Other
Quarterly dividend of $0.85 per share has an ex-dividend date of June 15, 2026, scheduled.
6/15/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Other
Ex-dividend date for a quarterly cash dividend of $1.25 per share on 2026-06-12. The dividend was declared on May 26, 2026, and is payable on June 26, 2026. A price impact of approximately 1% is expected based on the dividend amount.
6/12/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Other
Novo Nordisk to host an R&D investor event to discuss data from the ADA 2026 Scientific Sessions, including Phase 3 results for CagriSema on 2026-06-07; High importance is estimated as Phase 3 data for key pipeline assets typically drives >10% price movement, scheduled.
6/7/2026, 12:00:00 AM